Bioceltix SA (BCX) Ratios
Bioceltix SA Ratios
PL:BCX's free cash flow for Q2 2026 was $-3.82M. For the 2026 fiscal year, PL:BCX's free cash flow was decreased by $-1.27M and operating cash flow was $-2.55M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 32.51 | 12.34 | 5.24 | 1.94 | 3.42 |
| Quick Ratio | 32.51 | 12.33 | 5.24 | 1.94 | 3.42 |
| Cash Ratio | 31.19 | 10.52 | 4.35 | 1.83 | 3.18 |
| Solvency Ratio | -6.15 | -4.17 | -5.84 | -3.39 | -1.83 |
| Operating Cash Flow Ratio | -5.52 | -5.55 | -6.89 | -3.52 | -2.12 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -26.30 | -149.38 | -68.28 | -10.61 |
| Net Current Asset Value | $ 68.94M | $ 35.98M | $ 8.94M | $ 1.86M | $ 4.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.02 | 0.01 | 0.05 | 0.06 |
| Debt-to-Equity Ratio | 0.00 | 0.02 | 0.02 | 0.06 | 0.09 |
| Debt-to-Capital Ratio | 0.00 | 0.02 | 0.02 | 0.05 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.03 | 1.09 | 1.22 | 1.16 | 1.37 |
| Debt Service Coverage Ratio | -79.57 | -15.15 | -99.86 | -57.33 | -9.90 |
| Interest Coverage Ratio | -82.90 | -74.08 | -470.16 | -307.02 | -270.74 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.10 | 0.24 | 0.05 | 0.10 | 0.18 |
| Net Debt to EBITDA | 4.09 | 2.34 | 0.69 | 0.45 | 1.40 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.90% | 100.21% | 99.96% | 99.49% | 100.95% |
| EBT Per EBIT | 87.63% | 78.96% | 86.56% | 92.71% | 70.11% |
| Return on Assets (ROA) | -20.04% | -35.59% | -107.48% | -149.00% | -53.65% |
| Return on Equity (ROE) | -20.69% | -38.78% | -130.77% | -173.20% | -73.30% |
| Return on Capital Employed (ROCE) | -23.58% | -48.71% | -149.30% | -258.66% | -98.79% |
| Return on Invested Capital (ROIC) | -23.48% | -47.07% | -146.51% | -242.32% | -88.11% |
| Return on Tangible Assets | -20.04% | -35.59% | -107.48% | -149.00% | -53.65% |
| Earnings Yield | -3.91% | -3.75% | -3.88% | -6.89% | -2.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.06 | 0.38 | 0.86 | 0.46 | 1.31 |
| Inventory Turnover | 0.00 | 41.03 | 120.47 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -343.84 | -939.59 | -421.24 | -786.01 | -278.67 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 8.90 | 3.03 | 0.00 | 0.00 |
| Days of Payables Outstanding | 343.84 | 948.48 | 424.27 | 786.01 | 278.67 |
| Operating Cycle | 0.00 | 8.90 | 3.03 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.42 | -3.91 | -3.76 | -2.37 | -1.28 |
| Free Cash Flow Per Share | -2.81 | -3.96 | -3.88 | -2.48 | -1.28 |
| Dividend Paid and CapEx Coverage Ratio | -6.14 | -73.05 | -32.18 | -22.48 | -675.22 |
| Capital Expenditure Coverage Ratio | -6.14 | -73.05 | -32.18 | -22.48 | -675.22 |
| Operating Cash Flow Coverage Ratio | -38.43 | -21.53 | -84.25 | -26.90 | -7.61 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -3.63% | -4.52% | -4.31% | -6.38% | -2.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -25.61 | -26.71 | -25.77 | -14.51 | -37.54 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 5.29 | 10.34 | 33.70 | 25.13 | 27.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -27.57 | -22.10 | -23.20 | -15.67 | -40.80 |
| Price-to-Operating Cash Flow Ratio | -32.06 | -22.41 | -23.92 | -16.37 | -40.86 |
| Price-to-Earnings Growth (PEG) Ratio | 3.36 | 4.44 | -0.84 | -0.16 | -0.81 |
| Enterprise Value Multiple | -19.22 | -25.97 | -25.98 | -14.79 | -40.34 |
| Enterprise Value | 319.82M | 364.61M | 343.57M | 125.61M | 159.55M |
| EV to EBITDA | -19.22 | -25.97 | -25.98 | -14.79 | -40.34 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -22.73 | -20.28 | -22.59 | -15.21 | -39.43 |
| EV to Operating Cash Flow | -26.43 | -20.56 | -23.30 | -15.89 | -39.49 |
| Tangible Book Value Per Share | 14.66 | 8.47 | 2.67 | 1.04 | 1.90 |
| Shareholders’ Equity Per Share | 14.66 | 8.47 | 2.67 | 1.54 | 1.90 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | 0.01 | -0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -3.03 | -3.28 | -3.49 | -2.67 | -1.39 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.01 |
| Interest Burden | 0.88 | 1.02 | 1.00 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.80 | 1.19 | 1.08 | 0.89 | 0.92 |
Currency in PLN
